24
Jan

Despite the recent FDA rebuke of the blockbuster hopeful Lemtrada, Sanofi CEO Chris Viehbacher believes his company is poised to cash in on “a whole raft of new products” in the coming years.

…read more

Source: Sanofi CEO: Our pipeline is in the top 5

    

0 No comments